Financial Daily from THE HINDU group of publications
Wednesday, Oct 20, 2004
Financial Daily from THE HINDU group of publications Wednesday, Oct 20, 2004 |
||
|
|
||
|
Corporate
-
Announcements Panacea Biotech to develop new tech for vaccine storage Our Bureau
New Delhi , Oct. 19 PANACEA Biotec has entered into collaboration with UK-based Cambridge Biostability Ltd for manufacturing a technology that will do away with the need of having a cold chain for storage of vaccines. Speaking to Business Line, Mr Rajesh Jain, Joint Managing Director, Panacea, said, "This new technology, called stable liquid technology, has received £950,000 funding from the Department of International Development. By making vaccines stable across a range of temperatures, the new technology removes the need for the cold chain, which currently costs $200 million a year. It also gives vaccines a very long shelf life, which will save $100 million in wasted vaccines each year." The new technology is expected to take about a year or two to develop and another two years to commercialise. Through this deal, Panacea will have the production and export rights to all the vaccines using this technology," said Mr Jain.
More Stories on : Announcements | Bio-tech & Genetics
Article E-Mail :: Comment :: Syndication :: Printer Friendly Page
|
Stories in this Section |
|
The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription Group Sites: The Hindu | Business Line | Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |
Copyright © 2004, The
Hindu Business Line. Republication or redissemination of the contents of
this screen are expressly prohibited without the written consent of
The Hindu Business Line
|